![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[IMG]](/icons/image2.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| duphat_intra31-79x50..> | 2018-06-20 13:22 | 1.5K | |
| eplerenona-79x50.jpg | 2018-06-20 13:22 | 1.7K | |
| eplerenona1-79x50.jpg | 2018-06-20 13:22 | 1.7K | |
| eplerenona2-79x50.jpg | 2018-06-20 13:22 | 1.7K | |
| montelukast--79x50.jpg | 2018-06-20 13:22 | 2.0K | |
| montelukast-1-79x50.jpg | 2018-06-20 13:22 | 2.0K | |
| montelukast-2-79x50.jpg | 2018-06-20 13:22 | 2.0K | |
| duphat_intra3-79x50.jpg | 2018-06-20 13:22 | 2.0K | |
| duphat_intra2-79x50.jpg | 2018-06-20 13:22 | 2.0K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 2.0K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 2.0K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 2.0K | |
| Rabeprazol-79x50.jpg | 2018-06-20 13:22 | 2.1K | |
| Rabeprazol1-79x50.jpg | 2018-06-20 13:22 | 2.1K | |
| Rabeprazol2-79x50.jpg | 2018-06-20 13:22 | 2.1K | |
| duphat_intra1-79x50.jpg | 2018-06-20 13:22 | 2.1K | |
| Pharmagrip-Forte-79x..> | 2018-06-20 13:23 | 2.3K | |
| Pharmagrip-Forte1-79..> | 2018-06-20 13:23 | 2.3K | |
| Pharmagrip-Forte2-79..> | 2018-06-20 13:23 | 2.3K | |
| levetiracetam-79x50.jpg | 2018-06-20 13:22 | 2.4K | |
| levetiracetam1-79x50..> | 2018-06-20 13:22 | 2.4K | |
| levetiracetam2-79x50..> | 2018-06-20 13:22 | 2.4K | |
| duphat_intra-79x50.jpg | 2018-06-20 13:22 | 2.4K | |
| algeneric-79x50.jpg | 2018-06-20 13:22 | 3.0K | |
| eplerenona.jpg | 2018-06-20 13:22 | 3.8K | |
| eplerenona1.jpg | 2018-06-20 13:22 | 3.8K | |
| eplerenona2.jpg | 2018-06-20 13:22 | 3.8K | |
| eplerenona-150x114.jpg | 2018-06-20 13:22 | 4.0K | |
| eplerenona1-150x114.jpg | 2018-06-20 13:22 | 4.0K | |
| eplerenona2-150x114.jpg | 2018-06-20 13:22 | 4.0K | |
| duphat_intra31-150x1..> | 2018-06-20 13:22 | 4.6K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 4.7K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 4.7K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 4.7K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 4.9K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 4.9K | |
| montelukast-masticab..> | 2018-06-20 13:22 | 4.9K | |
| Rabeprazol.jpg | 2018-06-20 13:22 | 6.1K | |
| Rabeprazol1.jpg | 2018-06-20 13:22 | 6.1K | |
| Rabeprazol2.jpg | 2018-06-20 13:22 | 6.1K | |
| levetiracetam-150x15..> | 2018-06-20 13:22 | 6.1K | |
| levetiracetam1-150x1..> | 2018-06-20 13:22 | 6.1K | |
| levetiracetam2-150x1..> | 2018-06-20 13:22 | 6.1K | |
| duphat_intra1-150x15..> | 2018-06-20 13:22 | 6.2K | |
| duphat_intra3-150x15..> | 2018-06-20 13:22 | 6.3K | |
| duphat_intra2-150x15..> | 2018-06-20 13:22 | 6.3K | |
| montelukast--150x150..> | 2018-06-20 13:22 | 6.3K | |
| montelukast-1-150x15..> | 2018-06-20 13:22 | 6.3K | |
| montelukast-2-150x15..> | 2018-06-20 13:22 | 6.3K | |
| montelukast-.jpg | 2018-06-20 13:22 | 6.6K | |
| montelukast-1.jpg | 2018-06-20 13:22 | 6.6K | |
| montelukast-2.jpg | 2018-06-20 13:22 | 6.6K | |
| Rabeprazol-150x146.jpg | 2018-06-20 13:22 | 7.0K | |
| Rabeprazol1-150x146.jpg | 2018-06-20 13:22 | 7.0K | |
| Rabeprazol2-150x146.jpg | 2018-06-20 13:22 | 7.0K | |
| duphat_intra31-300x2..> | 2018-06-20 13:22 | 7.4K | |
| duphat_intra-150x150..> | 2018-06-20 13:22 | 7.5K | |
| Pharmagrip-Forte-150..> | 2018-06-20 13:23 | 8.1K | |
| Pharmagrip-Forte1-15..> | 2018-06-20 13:23 | 8.1K | |
| Pharmagrip-Forte2-15..> | 2018-06-20 13:23 | 8.1K | |
| levetiracetam.jpg | 2018-06-20 13:22 | 8.6K | |
| levetiracetam1.jpg | 2018-06-20 13:22 | 8.6K | |
| levetiracetam2.jpg | 2018-06-20 13:22 | 8.6K | |
| algeneric-150x150.jpg | 2018-06-20 13:22 | 9.4K | |
| duphat_intra3-300x20..> | 2018-06-20 13:22 | 9.8K | |
| duphat_intra2-300x21..> | 2018-06-20 13:22 | 11K | |
| duphat_intra1-300x23..> | 2018-06-20 13:22 | 12K | |
| Pharmagrip-Forte.jpg | 2018-06-20 13:23 | 13K | |
| Pharmagrip-Forte1.jpg | 2018-06-20 13:23 | 13K | |
| Pharmagrip-Forte2.jpg | 2018-06-20 13:23 | 13K | |
| duphat_intra-300x225..> | 2018-06-20 13:22 | 14K | |
| Pharmagrip-Forte-230..> | 2018-06-20 13:23 | 15K | |
| Pharmagrip-Forte1-23..> | 2018-06-20 13:23 | 15K | |
| Pharmagrip-Forte2-23..> | 2018-06-20 13:23 | 15K | |
| algeneric-300x168.jpg | 2018-06-20 13:22 | 19K | |
| duphat_intra31.jpg | 2018-06-20 13:22 | 29K | |
| bio_torasemida.pdf | 2018-06-20 13:22 | 30K | |
| bio_torasemida1.pdf | 2018-06-20 13:22 | 30K | |
| bio_torasemida2.pdf | 2018-06-20 13:22 | 30K | |
| duphat_intra.jpg | 2018-06-20 13:22 | 32K | |
| duphat_intra1.jpg | 2018-06-20 13:22 | 33K | |
| duphat_intra2.jpg | 2018-06-20 13:22 | 33K | |
| duphat_intra3.jpg | 2018-06-20 13:22 | 33K | |
| 327_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 327_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 327_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 327_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 297_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 297_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 297_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 330_prospecto_0.pdf | 2018-06-20 13:23 | 34K | |
| 330_prospecto_01.pdf | 2018-06-20 13:23 | 34K | |
| 331_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 331_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 331_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 346_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 346_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| 346_bioequivalencia_..> | 2018-06-20 13:23 | 34K | |
| curva_BE_irbesartan.pdf | 2018-06-20 13:22 | 37K | |
| curva_BE_irbesartan1..> | 2018-06-20 13:22 | 37K | |
| curva_BE_irbesartan2..> | 2018-06-20 13:22 | 37K | |
| 246_bioequivalencia_..> | 2018-06-20 13:23 | 38K | |
| 246_bioequivalencia_..> | 2018-06-20 13:23 | 38K | |
| 246_bioequivalencia_..> | 2018-06-20 13:23 | 38K | |
| Curva.bioequivalenci..> | 2018-06-20 13:23 | 39K | |
| Curva.bioequivalenci..> | 2018-06-20 13:23 | 39K | |
| Curva.bioequivalenci..> | 2018-06-20 13:23 | 39K | |
| 280_196_prospecto_0.pdf | 2018-06-20 13:23 | 42K | |
| 280_196_prospecto_01..> | 2018-06-20 13:23 | 42K | |
| 280_196_prospecto_02..> | 2018-06-20 13:23 | 42K | |
| 216_ficha_tecnica_0.pdf | 2018-06-20 13:23 | 42K | |
| 216_ficha_tecnica_01..> | 2018-06-20 13:23 | 42K | |
| 216_ficha_tecnica_02..> | 2018-06-20 13:23 | 42K | |
| 300_bioequivalencia_..> | 2018-06-20 13:23 | 43K | |
| 300_bioequivalencia_..> | 2018-06-20 13:23 | 43K | |
| 300_bioequivalencia_..> | 2018-06-20 13:23 | 43K | |
| 212_bioequivalencia_..> | 2018-06-20 13:23 | 45K | |
| 212_bioequivalencia_..> | 2018-06-20 13:23 | 45K | |
| 212_bioequivalencia_..> | 2018-06-20 13:23 | 45K | |
| 305_bioequivalencia_..> | 2018-06-20 13:23 | 46K | |
| 305_bioequivalencia_..> | 2018-06-20 13:23 | 46K | |
| 305_bioequivalencia_..> | 2018-06-20 13:23 | 46K | |
| 361_bioequivalencia_..> | 2018-06-20 13:23 | 47K | |
| 361_bioequivalencia_..> | 2018-06-20 13:23 | 47K | |
| 361_bioequivalencia_..> | 2018-06-20 13:23 | 47K | |
| 356_bioequivalencia_..> | 2018-06-20 13:23 | 47K | |
| 356_bioequivalencia_..> | 2018-06-20 13:23 | 47K | |
| 356_bioequivalencia_..> | 2018-06-20 13:23 | 47K | |
| 343_bioequivalencia_..> | 2018-06-20 13:23 | 48K | |
| 343_bioequivalencia_..> | 2018-06-20 13:23 | 48K | |
| 343_bioequivalencia_..> | 2018-06-20 13:23 | 48K | |
| 344_170_ficha_tecnic..> | 2018-06-20 13:23 | 49K | |
| 344_170_ficha_tecnic..> | 2018-06-20 13:23 | 49K | |
| 344_170_ficha_tecnic..> | 2018-06-20 13:23 | 49K | |
| 278_192_prospecto_0.pdf | 2018-06-20 13:23 | 49K | |
| 278_192_prospecto_01..> | 2018-06-20 13:23 | 49K | |
| 278_192_prospecto_02..> | 2018-06-20 13:23 | 49K | |
| 278_194_prospecto_0.pdf | 2018-06-20 13:23 | 49K | |
| 278_194_prospecto_01..> | 2018-06-20 13:23 | 49K | |
| 278_194_prospecto_02..> | 2018-06-20 13:23 | 49K | |
| 284_200_prospecto_0.pdf | 2018-06-20 13:23 | 50K | |
| 284_200_prospecto_01..> | 2018-06-20 13:23 | 50K | |
| 284_200_prospecto_02..> | 2018-06-20 13:23 | 50K | |
| 244_bioequivalencia_..> | 2018-06-20 13:23 | 51K | |
| 244_bioequivalencia_..> | 2018-06-20 13:23 | 51K | |
| 244_bioequivalencia_..> | 2018-06-20 13:23 | 51K | |
| 302_bioequivalencia_..> | 2018-06-20 13:23 | 52K | |
| 302_bioequivalencia_..> | 2018-06-20 13:23 | 52K | |
| 302_bioequivalencia_..> | 2018-06-20 13:23 | 52K | |
| 1766_bioequivalencia..> | 2018-06-20 13:24 | 54K | |
| 1766_bioequivalencia..> | 2018-06-20 13:24 | 54K | |
| 1766_bioequivalencia..> | 2018-06-20 13:24 | 54K | |
| 1867_2901_prospecto_..> | 2018-06-20 13:23 | 55K | |
| 1867_2901_prospecto_..> | 2018-06-20 13:23 | 55K | |
| 1867_2901_prospecto_..> | 2018-06-20 13:23 | 55K | |
| Prospectorespitol.pdf | 2018-06-20 13:22 | 59K | |
| Prospectorespitol1.pdf | 2018-06-20 13:22 | 59K | |
| Prospectorespitol2.pdf | 2018-06-20 13:22 | 59K | |
| BIO.carvedilol.pdf | 2018-06-20 13:23 | 59K | |
| BIO.carvedilol1.pdf | 2018-06-20 13:23 | 59K | |
| BIO.carvedilol2.pdf | 2018-06-20 13:23 | 59K | |
| 282_198_prospecto_0.pdf | 2018-06-20 13:23 | 59K | |
| 282_198_prospecto_01..> | 2018-06-20 13:23 | 59K | |
| 282_198_prospecto_02..> | 2018-06-20 13:23 | 59K | |
| Prospectogarydol.pdf | 2018-06-20 13:23 | 61K | |
| Prospectogarydol1.pdf | 2018-06-20 13:23 | 61K | |
| Prospectogarydol2.pdf | 2018-06-20 13:23 | 61K | |
| Prospectocinfamar50m..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamar50m..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamar50m..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamar50m..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamar50m..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamar50m..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamarcaf..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamarcaf..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamarcaf..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamarcaf..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamarcaf..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamarcaf..> | 2018-06-20 13:23 | 63K | |
| Prospectocinfamarinf..> | 2018-06-20 13:23 | 67K | |
| Prospectocinfamarinf..> | 2018-06-20 13:23 | 67K | |
| Prospectocinfamarinf..> | 2018-06-20 13:23 | 67K | |
| Prospectocinfamarinf..> | 2018-06-20 13:23 | 67K | |
| Prospectocinfamarinf..> | 2018-06-20 13:23 | 67K | |
| Prospectocinfamarinf..> | 2018-06-20 13:23 | 67K | |
| Prospectoibufengel.pdf | 2018-06-20 13:23 | 69K | |
| Prospectoibufengel1.pdf | 2018-06-20 13:23 | 69K | |
| Prospectoibufengel2.pdf | 2018-06-20 13:23 | 69K | |
| Prospectocinfatosexp..> | 2018-06-20 13:23 | 73K | |
| Prospectocinfatosexp..> | 2018-06-20 13:23 | 73K | |
| Prospectocinfatosexp..> | 2018-06-20 13:23 | 73K | |
| Prospectocinfatosexp..> | 2018-06-20 13:23 | 73K | |
| Prospectocinfatosexp..> | 2018-06-20 13:23 | 73K | |
| Prospectocinfatosexp..> | 2018-06-20 13:23 | 73K | |
| Prospectocinfatosjar..> | 2018-06-20 13:23 | 74K | |
| Prospectocinfatosjar..> | 2018-06-20 13:23 | 74K | |
| Prospectocinfatosjar..> | 2018-06-20 13:23 | 74K | |
| Prospectocinfatosjar..> | 2018-06-20 13:23 | 74K | |
| Prospectocinfatosjar..> | 2018-06-20 13:23 | 74K | |
| Prospectocinfatosjar..> | 2018-06-20 13:23 | 74K | |
| Prospectocinfatospas..> | 2018-06-20 13:23 | 74K | |
| Prospectocinfatospas..> | 2018-06-20 13:23 | 74K | |
| Prospectocinfatospas..> | 2018-06-20 13:23 | 74K | |
| Prospectoardoral.pdf | 2018-06-20 13:23 | 76K | |
| Prospectoardoral1.pdf | 2018-06-20 13:23 | 76K | |
| Prospectoardoral2.pdf | 2018-06-20 13:23 | 76K | |
| 330_bioequivalencia_..> | 2018-06-20 13:23 | 79K | |
| 330_bioequivalencia_..> | 2018-06-20 13:23 | 79K | |
| ProspectoibufA9n-com..> | 2018-06-20 13:23 | 80K | |
| ProspectoibufA9n-com..> | 2018-06-20 13:23 | 80K | |
| ProspectoibufA9n-com..> | 2018-06-20 13:23 | 80K | |
| Prospectomagnesiacin..> | 2018-06-20 13:23 | 81K | |
| Prospectomagnesiacin..> | 2018-06-20 13:23 | 81K | |
| Prospectomagnesiacin..> | 2018-06-20 13:23 | 81K | |
| P_cinfatos_infantil.pdf | 2018-06-20 13:23 | 82K | |
| P_cinfatos_infantil1..> | 2018-06-20 13:23 | 82K | |
| P_cinfatos_infantil2..> | 2018-06-20 13:23 | 82K | |
| P.magnesia_n.pdf | 2018-06-20 13:23 | 82K | |
| P.magnesia_n1.pdf | 2018-06-20 13:23 | 82K | |
| P.magnesia_n2.pdf | 2018-06-20 13:23 | 82K | |
| Prospectorespibien.pdf | 2018-06-20 13:22 | 83K | |
| Prospectorespibien1.pdf | 2018-06-20 13:22 | 83K | |
| Prospectorespibien2.pdf | 2018-06-20 13:22 | 83K | |
| Prospectoalercina.pdf | 2018-06-20 13:23 | 86K | |
| Prospectoalercina1.pdf | 2018-06-20 13:23 | 86K | |
| Prospectoalercina2.pdf | 2018-06-20 13:23 | 86K | |
| Prospectocinfatoscom..> | 2018-06-20 13:23 | 90K | |
| Prospectocinfatoscom..> | 2018-06-20 13:23 | 90K | |
| Prospectocinfatoscom..> | 2018-06-20 13:23 | 90K | |
| algeneric.jpg | 2018-06-20 13:22 | 90K | |
| 176_46_prospecto_0.pdf | 2018-06-20 13:24 | 92K | |
| 176_46_prospecto_01.pdf | 2018-06-20 13:24 | 92K | |
| 176_46_prospecto_02.pdf | 2018-06-20 13:24 | 92K | |
| Prospectodiarfin-1.pdf | 2018-06-20 13:23 | 92K | |
| Prospectodiarfin-11.pdf | 2018-06-20 13:23 | 92K | |
| Prospectodiarfin-12.pdf | 2018-06-20 13:23 | 92K | |
| Prospectodiarfin.pdf | 2018-06-20 13:23 | 92K | |
| Prospectodiarfin1.pdf | 2018-06-20 13:23 | 92K | |
| Prospectodiarfin2.pdf | 2018-06-20 13:23 | 92K | |
| 1830_prospecto_0.pdf | 2018-06-20 13:23 | 95K | |
| 1830_prospecto_01.pdf | 2018-06-20 13:23 | 95K | |
| 1830_prospecto_02.pdf | 2018-06-20 13:23 | 95K | |
| 361_prospecto_1.pdf | 2018-06-20 13:23 | 96K | |
| 361_prospecto_11.pdf | 2018-06-20 13:23 | 96K | |
| 361_prospecto_12.pdf | 2018-06-20 13:23 | 96K | |
| ProspectoPharmagripD..> | 2018-06-20 13:23 | 100K | |
| ProspectoPharmagripD..> | 2018-06-20 13:23 | 100K | |
| ProspectoPharmagripD..> | 2018-06-20 13:23 | 100K | |
| ProspectoPharmagripD..> | 2018-06-20 13:23 | 101K | |
| ProspectoPharmagripD..> | 2018-06-20 13:23 | 101K | |
| ProspectoPharmagripD..> | 2018-06-20 13:23 | 101K | |
| 1840_prospecto_0.pdf | 2018-06-20 13:23 | 104K | |
| 1829_prospecto_0.pdf | 2018-06-20 13:23 | 104K | |
| 1829_prospecto_01.pdf | 2018-06-20 13:23 | 104K | |
| 1829_prospecto_02.pdf | 2018-06-20 13:23 | 104K | |
| 1829_prospecto_1-1.pdf | 2018-06-20 13:23 | 104K | |
| 1829_prospecto_1-11.pdf | 2018-06-20 13:23 | 104K | |
| 1829_prospecto_1-12.pdf | 2018-06-20 13:23 | 104K | |
| 1798_prospecto_1.pdf | 2018-06-20 13:23 | 105K | |
| 1798_prospecto_11.pdf | 2018-06-20 13:23 | 105K | |
| 1798_prospecto_12.pdf | 2018-06-20 13:23 | 105K | |
| 246_prospecto_3.pdf | 2018-06-20 13:23 | 107K | |
| 246_prospecto_31.pdf | 2018-06-20 13:23 | 107K | |
| 246_prospecto_32.pdf | 2018-06-20 13:23 | 107K | |
| 356_prospecto_0.pdf | 2018-06-20 13:23 | 108K | |
| 356_prospecto_01.pdf | 2018-06-20 13:23 | 108K | |
| 356_prospecto_02.pdf | 2018-06-20 13:23 | 108K | |
| 331_prospecto_0.pdf | 2018-06-20 13:23 | 109K | |
| 331_prospecto_01.pdf | 2018-06-20 13:23 | 109K | |
| 331_prospecto_02.pdf | 2018-06-20 13:23 | 109K | |
| 331_prospecto_1.pdf | 2018-06-20 13:23 | 109K | |
| 331_prospecto_11.pdf | 2018-06-20 13:23 | 109K | |
| 331_prospecto_12.pdf | 2018-06-20 13:23 | 109K | |
| 331_prospecto_2.pdf | 2018-06-20 13:23 | 109K | |
| 331_prospecto_21.pdf | 2018-06-20 13:23 | 109K | |
| 331_prospecto_22.pdf | 2018-06-20 13:23 | 109K | |
| 341_prospecto_0.pdf | 2018-06-20 13:23 | 110K | |
| 341_prospecto_01.pdf | 2018-06-20 13:23 | 110K | |
| 341_prospecto_02.pdf | 2018-06-20 13:23 | 110K | |
| 1783_prospecto_0.pdf | 2018-06-20 13:24 | 111K | |
| 1783_prospecto_01.pdf | 2018-06-20 13:24 | 111K | |
| 1783_prospecto_02.pdf | 2018-06-20 13:24 | 111K | |
| 1851_prospecto_1.pdf | 2018-06-20 13:23 | 113K | |
| 1851_prospecto_11.pdf | 2018-06-20 13:23 | 113K | |
| 1851_prospecto_12.pdf | 2018-06-20 13:23 | 113K | |
| 1851_prospecto_0.pdf | 2018-06-20 13:23 | 113K | |
| 1851_prospecto_01.pdf | 2018-06-20 13:23 | 113K | |
| 1851_prospecto_02.pdf | 2018-06-20 13:23 | 113K | |
| 1851_prospecto_2.pdf | 2018-06-20 13:23 | 113K | |
| 1851_prospecto_21.pdf | 2018-06-20 13:23 | 113K | |
| 1851_prospecto_22.pdf | 2018-06-20 13:23 | 113K | |
| 212_prospecto_0.pdf | 2018-06-20 13:23 | 115K | |
| 212_prospecto_01.pdf | 2018-06-20 13:23 | 115K | |
| 212_prospecto_02.pdf | 2018-06-20 13:23 | 115K | |
| 1779_prospecto_0.pdf | 2018-06-20 13:24 | 116K | |
| 1779_prospecto_01.pdf | 2018-06-20 13:24 | 116K | |
| 1779_prospecto_02.pdf | 2018-06-20 13:24 | 116K | |
| 1779_prospecto_1.pdf | 2018-06-20 13:24 | 116K | |
| 1779_prospecto_11.pdf | 2018-06-20 13:24 | 116K | |
| 1779_prospecto_12.pdf | 2018-06-20 13:24 | 116K | |
| 212_prospecto_1.pdf | 2018-06-20 13:23 | 116K | |
| 212_prospecto_11.pdf | 2018-06-20 13:23 | 116K | |
| 212_prospecto_12.pdf | 2018-06-20 13:23 | 116K | |
| 1798_prospecto_0.pdf | 2018-06-20 13:23 | 116K | |
| 1798_prospecto_01.pdf | 2018-06-20 13:23 | 116K | |
| 1798_prospecto_02.pdf | 2018-06-20 13:23 | 116K | |
| 1763_prospecto_0.pdf | 2018-06-20 13:24 | 117K | |
| 1763_prospecto_01.pdf | 2018-06-20 13:24 | 117K | |
| 1763_prospecto_02.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_2.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_21.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_22.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_0.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_01.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_02.pdf | 2018-06-20 13:24 | 117K | |
| 1763_prospecto_1.pdf | 2018-06-20 13:24 | 117K | |
| 1763_prospecto_11.pdf | 2018-06-20 13:24 | 117K | |
| 1763_prospecto_12.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_1.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_11.pdf | 2018-06-20 13:24 | 117K | |
| 1788_prospecto_12.pdf | 2018-06-20 13:24 | 117K | |
| 343_prospecto_0.pdf | 2018-06-20 13:23 | 117K | |
| 343_prospecto_01.pdf | 2018-06-20 13:23 | 117K | |
| 343_prospecto_02.pdf | 2018-06-20 13:23 | 117K | |
| Prospectopharmagrip1..> | 2018-06-20 13:23 | 118K | |
| Prospectopharmagrip1..> | 2018-06-20 13:23 | 118K | |
| Prospectopharmagrip1..> | 2018-06-20 13:23 | 118K | |
| Prospectopharmagrip1..> | 2018-06-20 13:22 | 118K | |
| Prospectopharmagrip1..> | 2018-06-20 13:22 | 118K | |
| Prospectopharmagrip1..> | 2018-06-20 13:22 | 118K | |
| 343_prospecto_1.pdf | 2018-06-20 13:23 | 118K | |
| 343_prospecto_11.pdf | 2018-06-20 13:23 | 118K | |
| 343_prospecto_12.pdf | 2018-06-20 13:23 | 118K | |
| 343_prospecto_2.pdf | 2018-06-20 13:23 | 118K | |
| 343_prospecto_21.pdf | 2018-06-20 13:23 | 118K | |
| 343_prospecto_22.pdf | 2018-06-20 13:23 | 118K | |
| 330_153_ficha_tecnic..> | 2018-06-20 13:23 | 119K | |
| 330_153_ficha_tecnic..> | 2018-06-20 13:23 | 119K | |
| 302_prospecto_0.pdf | 2018-06-20 13:23 | 122K | |
| 302_prospecto_01.pdf | 2018-06-20 13:23 | 122K | |
| 302_prospecto_02.pdf | 2018-06-20 13:23 | 122K | |
| 302_prospecto_1.pdf | 2018-06-20 13:23 | 122K | |
| 302_prospecto_11.pdf | 2018-06-20 13:23 | 122K | |
| 302_prospecto_12.pdf | 2018-06-20 13:23 | 122K | |
| BIO_TRAMADOL.pdf | 2018-06-20 13:23 | 122K | |
| BIO_TRAMADOL1.pdf | 2018-06-20 13:23 | 122K | |
| BIO_TRAMADOL2.pdf | 2018-06-20 13:23 | 122K | |
| BIO_ZOLPIDEM.pdf | 2018-06-20 13:23 | 124K | |
| BIO_ZOLPIDEM1.pdf | 2018-06-20 13:23 | 124K | |
| BIO_ZOLPIDEM2.pdf | 2018-06-20 13:23 | 124K | |
| BIO_ZOLPIDEM3.pdf | 2018-06-20 13:23 | 124K | |
| bio_furosemida.pdf | 2018-06-20 13:22 | 124K | |
| bio_furosemida1.pdf | 2018-06-20 13:22 | 124K | |
| bio_furosemida2.pdf | 2018-06-20 13:22 | 124K | |
| bio_atenolol.pdf | 2018-06-20 13:22 | 125K | |
| bio_atenolol1.pdf | 2018-06-20 13:22 | 125K | |
| bio_atenolol2.pdf | 2018-06-20 13:22 | 125K | |
| 327_prospecto_0.pdf | 2018-06-20 13:23 | 125K | |
| 327_prospecto_01.pdf | 2018-06-20 13:23 | 125K | |
| 327_prospecto_02.pdf | 2018-06-20 13:23 | 125K | |
| 327_prospecto_03.pdf | 2018-06-20 13:23 | 125K | |
| 346_prospecto_0.pdf | 2018-06-20 13:23 | 125K | |
| 346_prospecto_01.pdf | 2018-06-20 13:23 | 125K | |
| 346_prospecto_02.pdf | 2018-06-20 13:23 | 125K | |
| 327_prospecto_1.pdf | 2018-06-20 13:23 | 125K | |
| 327_prospecto_11.pdf | 2018-06-20 13:23 | 125K | |
| 327_prospecto_12.pdf | 2018-06-20 13:23 | 125K | |
| 327_prospecto_13.pdf | 2018-06-20 13:23 | 125K | |
| 224_prospecto_2.pdf | 2018-06-20 13:23 | 126K | |
| 224_prospecto_21.pdf | 2018-06-20 13:23 | 126K | |
| 224_prospecto_22.pdf | 2018-06-20 13:23 | 126K | |
| 224_prospecto_0.pdf | 2018-06-20 13:23 | 126K | |
| 224_prospecto_01.pdf | 2018-06-20 13:23 | 126K | |
| 224_prospecto_02.pdf | 2018-06-20 13:23 | 126K | |
| 361_prospecto_0.pdf | 2018-06-20 13:23 | 126K | |
| 361_prospecto_01.pdf | 2018-06-20 13:23 | 126K | |
| 361_prospecto_02.pdf | 2018-06-20 13:23 | 126K | |
| 346_prospecto_1.pdf | 2018-06-20 13:23 | 126K | |
| 346_prospecto_11.pdf | 2018-06-20 13:23 | 126K | |
| 346_prospecto_12.pdf | 2018-06-20 13:23 | 126K | |
| 234_146_prospecto_0.pdf | 2018-06-20 13:23 | 126K | |
| 234_146_prospecto_01..> | 2018-06-20 13:23 | 126K | |
| 234_146_prospecto_02..> | 2018-06-20 13:23 | 126K | |
| 234_148_prospecto_0.pdf | 2018-06-20 13:23 | 126K | |
| 234_148_prospecto_01..> | 2018-06-20 13:23 | 126K | |
| 234_148_prospecto_02..> | 2018-06-20 13:23 | 126K | |
| BIO_%20QUINAPRIL.pdf | 2018-06-20 13:23 | 126K | |
| BIO_%20QUINAPRIL1.pdf | 2018-06-20 13:23 | 126K | |
| BIO_%20QUINAPRIL2.pdf | 2018-06-20 13:23 | 126K | |
| 1766_prospecto_1.pdf | 2018-06-20 13:24 | 126K | |
| 1766_prospecto_11.pdf | 2018-06-20 13:24 | 126K | |
| 1766_prospecto_12.pdf | 2018-06-20 13:24 | 126K | |
| 1766_prospecto_0.pdf | 2018-06-20 13:24 | 126K | |
| 1766_prospecto_01.pdf | 2018-06-20 13:24 | 126K | |
| 1766_prospecto_02.pdf | 2018-06-20 13:24 | 126K | |
| BIO_DOXAZOSIN.pdf | 2018-06-20 13:23 | 127K | |
| BIO_DOXAZOSIN1.pdf | 2018-06-20 13:23 | 127K | |
| BIO_DOXAZOSIN2.pdf | 2018-06-20 13:23 | 127K | |
| 1778_prospecto_1.pdf | 2018-06-20 13:24 | 127K | |
| 1778_prospecto_11.pdf | 2018-06-20 13:24 | 127K | |
| 1778_prospecto_12.pdf | 2018-06-20 13:24 | 127K | |
| 1778_prospecto_0.pdf | 2018-06-20 13:24 | 127K | |
| 1778_prospecto_01.pdf | 2018-06-20 13:24 | 127K | |
| 1778_prospecto_02.pdf | 2018-06-20 13:24 | 127K | |
| 246_prospecto_0.pdf | 2018-06-20 13:23 | 128K | |
| 246_prospecto_01.pdf | 2018-06-20 13:23 | 128K | |
| 246_prospecto_02.pdf | 2018-06-20 13:23 | 128K | |
| 1840_79_ficha_tecnic..> | 2018-06-20 13:23 | 129K | |
| 246_prospecto_1.pdf | 2018-06-20 13:23 | 129K | |
| 246_prospecto_11.pdf | 2018-06-20 13:23 | 129K | |
| 246_prospecto_12.pdf | 2018-06-20 13:23 | 129K | |
| 246_prospecto_2.pdf | 2018-06-20 13:23 | 129K | |
| 246_prospecto_21.pdf | 2018-06-20 13:23 | 129K | |
| 246_prospecto_22.pdf | 2018-06-20 13:23 | 129K | |
| 1794_prospecto_0.pdf | 2018-06-20 13:24 | 131K | |
| 1794_prospecto_01.pdf | 2018-06-20 13:24 | 131K | |
| 1794_prospecto_02.pdf | 2018-06-20 13:24 | 131K | |
| BIO_%20LISINOPRI.pdf | 2018-06-20 13:23 | 131K | |
| BIO_%20LISINOPRI1.pdf | 2018-06-20 13:23 | 131K | |
| BIO_%20LISINOPRI2.pdf | 2018-06-20 13:23 | 131K | |
| 1830_56_ficha_tecnic..> | 2018-06-20 13:23 | 132K | |
| 1830_56_ficha_tecnic..> | 2018-06-20 13:23 | 132K | |
| 1830_56_ficha_tecnic..> | 2018-06-20 13:23 | 132K | |
| BIO_%20TICLOPIDI.pdf | 2018-06-20 13:23 | 132K | |
| BIO_%20TICLOPIDI1.pdf | 2018-06-20 13:23 | 132K | |
| BIO_%20TICLOPIDI2.pdf | 2018-06-20 13:23 | 132K | |
| 1765_prospecto_0.pdf | 2018-06-20 13:24 | 134K | |
| 1765_prospecto_01.pdf | 2018-06-20 13:24 | 134K | |
| 1765_prospecto_02.pdf | 2018-06-20 13:24 | 134K | |
| 1765_prospecto_1.pdf | 2018-06-20 13:24 | 134K | |
| 1765_prospecto_11.pdf | 2018-06-20 13:24 | 134K | |
| 1765_prospecto_12.pdf | 2018-06-20 13:24 | 134K | |
| 1781_prospecto_0.pdf | 2018-06-20 13:24 | 135K | |
| 1781_prospecto_01.pdf | 2018-06-20 13:24 | 135K | |
| 1781_prospecto_02.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_2.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_21.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_22.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_3.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_31.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_32.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_0.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_01.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_02.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_1.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_11.pdf | 2018-06-20 13:24 | 135K | |
| 1780_prospecto_12.pdf | 2018-06-20 13:24 | 135K | |
| 224_prospecto_1.pdf | 2018-06-20 13:23 | 135K | |
| 224_prospecto_11.pdf | 2018-06-20 13:23 | 135K | |
| 224_prospecto_12.pdf | 2018-06-20 13:23 | 135K | |
| 212_91_ficha_tecnica..> | 2018-06-20 13:23 | 137K | |
| 212_91_ficha_tecnica..> | 2018-06-20 13:23 | 137K | |
| 212_91_ficha_tecnica..> | 2018-06-20 13:23 | 137K | |
| 1877_prospecto_0.pdf | 2018-06-20 13:23 | 138K | |
| 1877_prospecto_01.pdf | 2018-06-20 13:23 | 138K | |
| 1877_prospecto_02.pdf | 2018-06-20 13:23 | 138K | |
| 327_157_ficha_tecnic..> | 2018-06-20 13:23 | 139K | |
| 327_157_ficha_tecnic..> | 2018-06-20 13:23 | 139K | |
| 327_157_ficha_tecnic..> | 2018-06-20 13:23 | 139K | |
| 327_157_ficha_tecnic..> | 2018-06-20 13:23 | 139K | |
| 1779_64_ficha_tecnic..> | 2018-06-20 13:24 | 139K | |
| 1779_64_ficha_tecnic..> | 2018-06-20 13:24 | 139K | |
| 1779_64_ficha_tecnic..> | 2018-06-20 13:24 | 139K | |
| 1808_prospecto_0.pdf | 2018-06-20 13:23 | 139K | |
| 1808_prospecto_01.pdf | 2018-06-20 13:23 | 139K | |
| 1808_prospecto_02.pdf | 2018-06-20 13:23 | 139K | |
| 1766_prospecto_2.pdf | 2018-06-20 13:24 | 139K | |
| 1766_prospecto_21.pdf | 2018-06-20 13:24 | 139K | |
| 1766_prospecto_22.pdf | 2018-06-20 13:24 | 139K | |
| 1808_prospecto_2.pdf | 2018-06-20 13:23 | 139K | |
| 1808_prospecto_21.pdf | 2018-06-20 13:23 | 139K | |
| 1808_prospecto_22.pdf | 2018-06-20 13:23 | 139K | |
| 1808_prospecto_1.pdf | 2018-06-20 13:23 | 139K | |
| 1808_prospecto_11.pdf | 2018-06-20 13:23 | 139K | |
| 1808_prospecto_12.pdf | 2018-06-20 13:23 | 139K | |
| 244_prospecto_1.pdf | 2018-06-20 13:23 | 142K | |
| 244_prospecto_11.pdf | 2018-06-20 13:23 | 142K | |
| 244_prospecto_12.pdf | 2018-06-20 13:23 | 142K | |
| 305_prospecto_0.pdf | 2018-06-20 13:23 | 142K | |
| 305_prospecto_01.pdf | 2018-06-20 13:23 | 142K | |
| 305_prospecto_02.pdf | 2018-06-20 13:23 | 142K | |
| 244_prospecto_0.pdf | 2018-06-20 13:23 | 142K | |
| 244_prospecto_01.pdf | 2018-06-20 13:23 | 142K | |
| 244_prospecto_02.pdf | 2018-06-20 13:23 | 142K | |
| 244_prospecto_2.pdf | 2018-06-20 13:23 | 142K | |
| 244_prospecto_21.pdf | 2018-06-20 13:23 | 142K | |
| 244_prospecto_22.pdf | 2018-06-20 13:23 | 142K | |
| 305_prospecto_1.pdf | 2018-06-20 13:23 | 142K | |
| 305_prospecto_11.pdf | 2018-06-20 13:23 | 142K | |
| 305_prospecto_12.pdf | 2018-06-20 13:23 | 142K | |
| venlafaxina-150.pdf | 2018-06-20 13:22 | 143K | |
| venlafaxina-1501.pdf | 2018-06-20 13:22 | 143K | |
| venlafaxina-1502.pdf | 2018-06-20 13:22 | 143K | |
| BIO_CAPTOPRI.pdf | 2018-06-20 13:23 | 144K | |
| BIO_CAPTOPRI1.pdf | 2018-06-20 13:23 | 144K | |
| BIO_CAPTOPRI2.pdf | 2018-06-20 13:23 | 144K | |
| venlafaxina-75.pdf | 2018-06-20 13:22 | 146K | |
| venlafaxina-751.pdf | 2018-06-20 13:22 | 146K | |
| venlafaxina-752.pdf | 2018-06-20 13:22 | 146K | |
| 1833_prospecto_1.pdf | 2018-06-20 13:23 | 147K | |
| 1833_prospecto_11.pdf | 2018-06-20 13:23 | 147K | |
| 1833_prospecto_12.pdf | 2018-06-20 13:23 | 147K | |
| 1798_41_ficha_tecnic..> | 2018-06-20 13:24 | 147K | |
| 1798_41_ficha_tecnic..> | 2018-06-20 13:24 | 147K | |
| 1798_41_ficha_tecnic..> | 2018-06-20 13:24 | 147K | |
| 356_179_ficha_tecnic..> | 2018-06-20 13:23 | 148K | |
| 356_179_ficha_tecnic..> | 2018-06-20 13:23 | 148K | |
| 356_179_ficha_tecnic..> | 2018-06-20 13:23 | 148K | |
| 1794_26_ficha_tecnic..> | 2018-06-20 13:24 | 148K | |
| 1794_26_ficha_tecnic..> | 2018-06-20 13:24 | 148K | |
| 1794_26_ficha_tecnic..> | 2018-06-20 13:24 | 148K | |
| 1833_prospecto_0.pdf | 2018-06-20 13:23 | 148K | |
| 1833_prospecto_01.pdf | 2018-06-20 13:23 | 148K | |
| 1833_prospecto_02.pdf | 2018-06-20 13:23 | 148K | |
| 1783_30_ficha_tecnic..> | 2018-06-20 13:24 | 149K | |
| 1783_30_ficha_tecnic..> | 2018-06-20 13:24 | 149K | |
| 1783_30_ficha_tecnic..> | 2018-06-20 13:24 | 149K | |
| 1829_80_ficha_tecnic..> | 2018-06-20 13:23 | 150K | |
| 1829_80_ficha_tecnic..> | 2018-06-20 13:23 | 150K | |
| 1829_80_ficha_tecnic..> | 2018-06-20 13:23 | 150K | |
| Prospectopazbronquia..> | 2018-06-20 13:23 | 150K | |
| Prospectopazbronquia..> | 2018-06-20 13:23 | 150K | |
| Prospectopazbronquia..> | 2018-06-20 13:23 | 150K | |
| 300_prospecto_0.pdf | 2018-06-20 13:23 | 150K | |
| 300_prospecto_01.pdf | 2018-06-20 13:23 | 150K | |
| 300_prospecto_02.pdf | 2018-06-20 13:23 | 150K | |
| 1780_29_ficha_tecnic..> | 2018-06-20 13:24 | 150K | |
| 1780_29_ficha_tecnic..> | 2018-06-20 13:24 | 150K | |
| 1780_29_ficha_tecnic..> | 2018-06-20 13:24 | 150K | |
| 361_180_ficha_tecnic..> | 2018-06-20 13:23 | 151K | |
| 361_180_ficha_tecnic..> | 2018-06-20 13:23 | 151K | |
| 361_180_ficha_tecnic..> | 2018-06-20 13:23 | 151K | |
| 341_167_ficha_tecnic..> | 2018-06-20 13:23 | 152K | |
| 341_167_ficha_tecnic..> | 2018-06-20 13:23 | 152K | |
| 341_167_ficha_tecnic..> | 2018-06-20 13:23 | 152K | |
| 1781_65_ficha_tecnic..> | 2018-06-20 13:24 | 155K | |
| 1781_65_ficha_tecnic..> | 2018-06-20 13:24 | 155K | |
| 1781_65_ficha_tecnic..> | 2018-06-20 13:24 | 155K | |
| 297_prospecto_1.pdf | 2018-06-20 13:23 | 158K | |
| 297_prospecto_11.pdf | 2018-06-20 13:23 | 158K | |
| 297_prospecto_12.pdf | 2018-06-20 13:23 | 158K | |
| 297_prospecto_0.pdf | 2018-06-20 13:23 | 158K | |
| 297_prospecto_01.pdf | 2018-06-20 13:23 | 158K | |
| 297_prospecto_02.pdf | 2018-06-20 13:23 | 158K | |
| 1764_prospecto_0.pdf | 2018-06-20 13:24 | 161K | |
| 1764_prospecto_01.pdf | 2018-06-20 13:24 | 161K | |
| 1764_prospecto_02.pdf | 2018-06-20 13:24 | 161K | |
| 1764_prospecto_03.pdf | 2018-06-20 13:24 | 161K | |
| 1854_45_ficha_tecnic..> | 2018-06-20 13:23 | 162K | |
| 1854_45_ficha_tecnic..> | 2018-06-20 13:23 | 162K | |
| 1854_45_ficha_tecnic..> | 2018-06-20 13:23 | 162K | |
| 300_133_ficha_tecnic..> | 2018-06-20 13:23 | 166K | |
| 300_133_ficha_tecnic..> | 2018-06-20 13:23 | 166K | |
| 300_133_ficha_tecnic..> | 2018-06-20 13:23 | 166K | |
| 305_136_ficha_tecnic..> | 2018-06-20 13:23 | 170K | |
| 305_136_ficha_tecnic..> | 2018-06-20 13:23 | 170K | |
| 305_136_ficha_tecnic..> | 2018-06-20 13:23 | 170K | |
| 1763_21_ficha_tecnic..> | 2018-06-20 13:24 | 170K | |
| 1763_21_ficha_tecnic..> | 2018-06-20 13:24 | 170K | |
| 1763_21_ficha_tecnic..> | 2018-06-20 13:24 | 170K | |
| 1854_prospecto_0.pdf | 2018-06-20 13:23 | 174K | |
| 1854_prospecto_01.pdf | 2018-06-20 13:23 | 174K | |
| 1854_prospecto_02.pdf | 2018-06-20 13:23 | 174K | |
| 1765_97_ficha_tecnic..> | 2018-06-20 13:24 | 174K | |
| 1765_97_ficha_tecnic..> | 2018-06-20 13:24 | 174K | |
| 1765_97_ficha_tecnic..> | 2018-06-20 13:24 | 174K | |
| 182_88_prospecto_0.pdf | 2018-06-20 13:23 | 176K | |
| 182_88_prospecto_01.pdf | 2018-06-20 13:23 | 176K | |
| 182_88_prospecto_02.pdf | 2018-06-20 13:23 | 176K | |
| 302_135_ficha_tecnic..> | 2018-06-20 13:23 | 177K | |
| 302_135_ficha_tecnic..> | 2018-06-20 13:23 | 177K | |
| 302_135_ficha_tecnic..> | 2018-06-20 13:23 | 177K | |
| 343_171_ficha_tecnic..> | 2018-06-20 13:23 | 177K | |
| 343_171_ficha_tecnic..> | 2018-06-20 13:23 | 177K | |
| 343_171_ficha_tecnic..> | 2018-06-20 13:23 | 177K | |
| 347_prospecto_0.pdf | 2018-06-20 13:23 | 179K | |
| 347_prospecto_01.pdf | 2018-06-20 13:23 | 179K | |
| 347_prospecto_02.pdf | 2018-06-20 13:23 | 179K | |
| 246_11_ficha_tecnica..> | 2018-06-20 13:23 | 180K | |
| 246_11_ficha_tecnica..> | 2018-06-20 13:23 | 180K | |
| 246_11_ficha_tecnica..> | 2018-06-20 13:23 | 180K | |
| 1788_22_ficha_tecnic..> | 2018-06-20 13:24 | 180K | |
| 1788_22_ficha_tecnic..> | 2018-06-20 13:24 | 180K | |
| 1788_22_ficha_tecnic..> | 2018-06-20 13:24 | 180K | |
| 1808_36_ficha_tecnic..> | 2018-06-20 13:23 | 183K | |
| 1808_36_ficha_tecnic..> | 2018-06-20 13:23 | 183K | |
| 1808_36_ficha_tecnic..> | 2018-06-20 13:23 | 183K | |
| 346_172_ficha_tecnic..> | 2018-06-20 13:23 | 185K | |
| 346_172_ficha_tecnic..> | 2018-06-20 13:23 | 185K | |
| 346_172_ficha_tecnic..> | 2018-06-20 13:23 | 185K | |
| 246_8_ficha_tecnica_..> | 2018-06-20 13:23 | 185K | |
| 246_8_ficha_tecnica_..> | 2018-06-20 13:23 | 185K | |
| 246_8_ficha_tecnica_..> | 2018-06-20 13:23 | 185K | |
| 246_9_ficha_tecnica_..> | 2018-06-20 13:23 | 188K | |
| 246_9_ficha_tecnica_..> | 2018-06-20 13:23 | 188K | |
| 246_9_ficha_tecnica_..> | 2018-06-20 13:23 | 188K | |
| 246_10_ficha_tecnica..> | 2018-06-20 13:23 | 188K | |
| 246_10_ficha_tecnica..> | 2018-06-20 13:23 | 188K | |
| 246_10_ficha_tecnica..> | 2018-06-20 13:23 | 188K | |
| 1851_75_ficha_tecnic..> | 2018-06-20 13:23 | 189K | |
| 1851_75_ficha_tecnic..> | 2018-06-20 13:23 | 189K | |
| 1851_75_ficha_tecnic..> | 2018-06-20 13:23 | 189K | |
| 1766_96_ficha_tecnic..> | 2018-06-20 13:24 | 190K | |
| 1766_96_ficha_tecnic..> | 2018-06-20 13:24 | 190K | |
| 1766_96_ficha_tecnic..> | 2018-06-20 13:24 | 190K | |
| 331_154_ficha_tecnic..> | 2018-06-20 13:23 | 197K | |
| 331_154_ficha_tecnic..> | 2018-06-20 13:23 | 197K | |
| 331_154_ficha_tecnic..> | 2018-06-20 13:23 | 197K | |
| 1778_28_ficha_tecnic..> | 2018-06-20 13:24 | 199K | |
| 1778_28_ficha_tecnic..> | 2018-06-20 13:24 | 199K | |
| 1778_28_ficha_tecnic..> | 2018-06-20 13:24 | 199K | |
| 1833_81_ficha_tecnic..> | 2018-06-20 13:23 | 206K | |
| 1833_81_ficha_tecnic..> | 2018-06-20 13:23 | 206K | |
| 1833_81_ficha_tecnic..> | 2018-06-20 13:23 | 206K | |
| Prosp-N+S-Tensium-12..> | 2018-06-20 13:23 | 207K | |
| trimetazidinacurvabi..> | 2018-06-20 13:22 | 213K | |
| trimetazidinacurvabi..> | 2018-06-20 13:22 | 213K | |
| trimetazidinacurvabi..> | 2018-06-20 13:22 | 213K | |
| 1764_60_ficha_tecnic..> | 2018-06-20 13:24 | 214K | |
| 1764_60_ficha_tecnic..> | 2018-06-20 13:24 | 214K | |
| 1764_60_ficha_tecnic..> | 2018-06-20 13:24 | 214K | |
| 244_12_ficha_tecnica..> | 2018-06-20 13:23 | 216K | |
| 244_12_ficha_tecnica..> | 2018-06-20 13:23 | 216K | |
| 244_12_ficha_tecnica..> | 2018-06-20 13:23 | 216K | |
| 244_13_ficha_tecnica..> | 2018-06-20 13:23 | 217K | |
| 244_13_ficha_tecnica..> | 2018-06-20 13:23 | 217K | |
| 244_13_ficha_tecnica..> | 2018-06-20 13:23 | 217K | |
| 244_14_ficha_tecnica..> | 2018-06-20 13:23 | 217K | |
| 244_14_ficha_tecnica..> | 2018-06-20 13:23 | 217K | |
| 244_14_ficha_tecnica..> | 2018-06-20 13:23 | 217K | |
| NORFLOXACINO.pdf | 2018-06-20 13:23 | 219K | |
| 224_116_ficha_tecnic..> | 2018-06-20 13:23 | 220K | |
| 224_116_ficha_tecnic..> | 2018-06-20 13:23 | 220K | |
| 224_116_ficha_tecnic..> | 2018-06-20 13:23 | 220K | |
| 354_prospecto_0.pdf | 2018-06-20 13:23 | 223K | |
| 354_prospecto_01.pdf | 2018-06-20 13:23 | 223K | |
| 354_prospecto_02.pdf | 2018-06-20 13:23 | 223K | |
| bio%20%20Venlafaxina..> | 2018-06-20 13:22 | 231K | |
| bio%20%20Venlafaxina..> | 2018-06-20 13:22 | 231K | |
| bio%20%20Venlafaxina..> | 2018-06-20 13:22 | 231K | |
| Prosp-cispreven_.pdf | 2018-06-20 13:23 | 232K | |
| 347_173_ficha_tecnic..> | 2018-06-20 13:23 | 240K | |
| 347_173_ficha_tecnic..> | 2018-06-20 13:23 | 240K | |
| 347_173_ficha_tecnic..> | 2018-06-20 13:23 | 240K | |
| BIO_ENALAPRIL1.pdf | 2018-06-20 13:23 | 243K | |
| BIO_ENALAPRIL11.pdf | 2018-06-20 13:23 | 243K | |
| BIO_ENALAPRIL12.pdf | 2018-06-20 13:23 | 243K | |
| Prosp-N+S-Premenop-1..> | 2018-06-20 13:23 | 250K | |
| Prosp-N+S-Menopau-12..> | 2018-06-20 13:23 | 270K | |
| 297_130_ficha_tecnic..> | 2018-06-20 13:23 | 312K | |
| 297_130_ficha_tecnic..> | 2018-06-20 13:23 | 312K | |
| 297_130_ficha_tecnic..> | 2018-06-20 13:23 | 312K | |
| Prospecto-drenante.pdf | 2018-06-20 13:23 | 371K | |
| Prospecto-drenante1.pdf | 2018-06-20 13:23 | 371K | |
| Prospecto-drenante2.pdf | 2018-06-20 13:23 | 371K | |
| OMEGA3-nuevo_abril20..> | 2018-06-20 13:23 | 437K | |
| FT-CETIRIZINA.pdf | 2018-06-20 13:23 | 470K | |
| FT-CETIRIZINA1.pdf | 2018-06-20 13:23 | 470K | |
| FT-CETIRIZINA2.pdf | 2018-06-20 13:23 | 470K | |
| VENLAFAXINA.pdf | 2018-06-20 13:23 | 1.2M | |
| VENLAFAXINA1.pdf | 2018-06-20 13:22 | 1.2M | |
| VENLAFAXINA2.pdf | 2018-06-20 13:22 | 1.2M | |
| 220_114_prospecto_0.pdf | 2018-06-20 13:23 | 1.4M | |
| 220_114_prospecto_01..> | 2018-06-20 13:23 | 1.4M | |
| 220_114_prospecto_02..> | 2018-06-20 13:23 | 1.4M | |
| 220_116_prospecto_0.pdf | 2018-06-20 13:23 | 1.5M | |
| 220_116_prospecto_01..> | 2018-06-20 13:23 | 1.5M | |
| 220_116_prospecto_02..> | 2018-06-20 13:23 | 1.5M | |